GLAXOSMITHKLINE PHARMA A/S: Financial statements 2019
CVR: 27394019
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 417,448,000 and a net result of DKK 11,096,000 compared with DKK 17,523,000 the year before. That is an increase of 0.9% compared with the year before. The profit margin was 2.7%. Equity in the 2019 report amounted to DKK 35,523,000. The solvency ratio was 20.5%. The company had 68 employees in the financial year.
- Revenue
- DKK 417,448,000
- Gross Profit
- DKK 114,300,000
- Profit/Loss
- DKK 11,096,000
- Equity
- DKK 35,523,000
- Total Assets
- DKK 173,563,000
- Employees
- 68
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 417.4M | 114.3M | 11.1M | 35.5M | 68 |
| 2018 | 413.8M | 116.3M | 17.5M | 39.4M | 80 |
| 2017 | 426.9M | 124.4M | 9.6M | 35.4M | 87 |
| 2016 | 366.5M | 81.8M | 1.9M | 25.8M | 92 |
| 2015 | 338.9M | 111.7M | 3.7M | 147.9M | 87 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2018. Revenue came to DKK 413,846,000, and the net result was DKK 17,523,000.
About GLAXOSMITHKLINE PHARMA A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.